Physician profile
Brian E Harvey
NPI 1285636217
$220,498.85
in general payments reported to CMS, 2019-2025
6 companies · $14K in 2025
The $14K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,874 · 2020: $31K · 2021: $7,875 · 2022: $49K · 2023: $5,625 · 2024: $107K · 2025: $14K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $126K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $126,300.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Beckman Coulter, INC. | $106,500.00 | 2024 | Dxi 9000 Access Immunoassay Analyzer |
| Diasorin INC. | $59,625.00 | 2019-2025 | Liaison Lymedetect, Various |
| Organon LLC | $40,300.00 | 2022 | |
| Coherus Oncology, INC. | $8,750.00 | 2020 | |
| Redhill Biopharma INC. | $4,750.00 | 2020 | |
| Vertex Pharmaceuticals Incorporated | $573.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Harvey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.